Arpino, Grazia (2006) Complete disappearance of ER+/HER2+ breast cancer xenografts with the combination of gefitinib, trastuzumab, and pertuzumab to block HER2 cross-talk with ER and restore tamoxifen inhibition. [Tesi di dottorato] (Unpublished)

[img] PDF
Arpino_Oncologia_Endocrinologia_Molecolare.pdf
Restricted to Repository staff only

Download (622kB)
Item Type: Tesi di dottorato
Depositing User: Staff Staff
Date Deposited: 18 Jun 2008
Last Modified: 30 Apr 2014 19:30
URI: http://www.fedoa.unina.it/id/eprint/2448

Actions (login required)

View Item View Item